Abstract:Cancer is a global health issue that is rising swiftly with younger people and an increased number of patients. The role of human microbiota in the pathophysiology of tumors has been paid more and more attention. Microecologics including prebiotics, probiotics, and synbiotics are among the best validated/proven resources for the application of microbiological prophylaxis and therapy. There is strong evidence that microecologics have anti-cancer activity and their potential association with cancer is significant. In this review, we will focus on the role of prebiotics, probiotics, and synbiotics in tumor suppression in maintaining the colon barrier, metabolism, immune regulation, inhibition of host tumor cell proliferation, and epidemiological-based recommendations. Besides, other signs illuminate the role of microecological agents to adjunct the cancer treatment and counter the toxic side effects of cancer drugs. In addition, we will explore their role in chemotherapy, where these probiotics can be used as an adjunct to chemotherapy, counteracting the toxic side effects of chemotherapy drugs to minimize or optimize the therapeutic effect. In the treatment of cancer, we can see the role of prebiotics, probiotics, synbiotics, and their application in cancer patients, and the effectiveness effect can be considered as a clinical benefit. PRACTICAL APPLICATIONS: A large number of studies have shown that microecologics including prebiotics, probiotics, and synbiotics play an important role in regulating intestinal microecology and contribute to the prevention and treatment of cancer, indicating that prebiotics, probiotics, and synbiotics have the potential to be used as microecological modulators in the adjuvant therapy of cancer. However, it is not clear what is the anti-tumor mechanism of these microecologics and how they antagonize the side effects of cancer chemotherapy and protect normal cells. This paper reviews the role of prebiotics, probiotics, and synbiotics in tumor suppression in maintaining the colon barrier, metabolism, immune regulation, and prevention of rapid growth of host cells, as well as their potential role in cancer chemotherapy. This review helps to better understand the relationship between prebiotics, probiotics, and synbiotics with immune regulation, intestinal microecology, metabolic regulation, and cell proliferation and provides strong evidence for their potential application as microecologics in cancer adjuvant therapy.

Molecular crosstalk between polyphenols and gut microbiota in cancer prevention

The Pivotal Role of the Gut Microbiome in Colorectal Cancer

Exploring gut microbial metabolites as key players in inhibition of cancer progression: Mechanisms and therapeutic implications

Gut microbiota, an emergent target to shape the efficiency of cancer therapy

Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications

Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action

Nutrigenomics: Epigenetics and cancer prevention: A comprehensive review

Harmony unveiled: Intricate the interplay of dietary factor, gut microbiota, and colorectal cancer-A narrative review

Potential of Synbiotics and Probiotics as Chemopreventive Agent

Current insights into epigenetics, noncoding RNA interactome and clinical pharmacokinetics of dietary polyphenols in cancer chemoprevention

Ecosystemic Approach to Understanding Gut Microbiome-Mediated Prevention of Colorectal Cancer

The Potential Role of Prebiotics, Probiotics, and Synbiotics in Adjuvant Cancer Therapy Especially Colorectal Cancer

Interactions between Dietary Antioxidants, Dietary Fiber and the Gut Microbiome: Their Putative Role in Inflammation and Cancer

Modulation of Gut Microbial Biomarkers and Metabolites in Cancer Management by Tea Compounds

Microbiome modulation in the prevention and management of colorectal cancer: a systematic review of clinical interventions

The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy

Chemical Compounds of Berry-Derived Polyphenols and Their Effects on Gut Microbiota, Inflammation, and Cancer

Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy

Modulating gut microbiota using nanotechnology to increase anticancer efficacy of the treatments

Diet as a modifiable factor in tumorigenesis: Focus on microbiome-derived bile acid metabolites and short-chain fatty acids

Emerging Evidence on the Effects of Dietary Factors on the Gut Microbiome in Colorectal Cancer